Insights+: The US FDA New Drug Approvals in January 2023
PharmaShots
FEBRUARY 15, 2023
Shots: The US FDA approved 8 NDAs and 1 BLA in January 2023, leading to treatments for patients and advances in the healthcare industry. insurance coverage & co-pay programs. At the same time, PAP offers Leqembi at no cost for eligible uninsured & underinsured patients, incl.
Let's personalize your content